BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37443145)

  • 1. TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells.
    Kitajima H; Maruyama R; Niinuma T; Yamamoto E; Takasawa A; Takasawa K; Ishiguro K; Tsuyada A; Suzuki R; Sudo G; Kubo T; Mitsuhashi K; Idogawa M; Tange S; Toyota M; Yoshido A; Kumegawa K; Kai M; Yanagihara K; Tokino T; Osanai M; Nakase H; Suzuki H
    Cell Death Dis; 2023 Jul; 14(7):424. PubMed ID: 37443145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and mechanism of downregulating the long-chain noncoding RNA TM4SF1-AS1 on the proliferation, apoptosis and invasion of gastric cancer cells.
    He C; Qi W; Wang Z
    World J Surg Oncol; 2021 Jul; 19(1):226. PubMed ID: 34330293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
    Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p.
    Jiang H; Li W; Xue Z; Chen W; Zhao L; Song H; Hou J
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101915. PubMed ID: 35346892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
    Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
    Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.
    Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S
    J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.
    Liu HT; Zou YX; Zhu WJ; Sen-Liu ; Zhang GH; Ma RR; Guo XY; Gao P
    Cell Death Differ; 2022 Mar; 29(3):627-641. PubMed ID: 34608273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion.
    Zhang LL; Zhang LF; Guo XH; Zhang DZ; Yang F; Fan YY
    DNA Cell Biol; 2018 Jan; 37(1):46-52. PubMed ID: 29215918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA Solute Carrier Family 25 Member 21 Antisense RNA 1 Inhibits Cell Malignant Behaviors and Enhances Radiosensitivity of Gastric Cancer Cells by Upregulating Synuclein Gamma Expression.
    Wang L; Wang Z; Wang L
    Tohoku J Exp Med; 2022 Jun; 257(3):225-239. PubMed ID: 35444105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling.
    Zhou C; An N; Cao C; Wang G
    J Gene Med; 2020 Sep; 22(9):e3202. PubMed ID: 32307743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
    Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
    J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-501-3p targeting TM4SF1 facilitates tumor-related behaviors of gastric cancer cells via EMT signaling pathway.
    Wei Y; Yin L; Xie X; Wu Z; Zhang J; Gao Y; Tang J
    Mutat Res; 2022; 825():111802. PubMed ID: 36274500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ASH1L-AS1-ASH1L axis controls NME1-mediated activation of the RAS signaling in gastric cancer.
    Xie M; Zhang L; Han L; Huang L; Huang Y; Yang M; Zhang N
    Oncogene; 2023 Nov; 42(46):3435-3445. PubMed ID: 37805663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
    Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
    J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel lncRNA GPC5-AS1 stabilizes GPC5 mRNA by competitively binding with miR-93/106a to suppress gastric cancer cell proliferation.
    Bo G; Liu Y; Li W; Wang L; Zhao L; Tong D; Ni L; Liu L; Qin Y; Wang W; Huang C
    Aging (Albany NY); 2022 Feb; 14(4):1767-1781. PubMed ID: 35183057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LGALS8-AS1 facilitates PLAGL2-mediated malignant phenotypes in gastric cancer.
    Wang G; Shen K; Xiao J; Fan H; Wang Y; Liu K; Zhou X; Cheng Q; Miao Y; Xu Z; Yang L
    J Gene Med; 2023 Jun; 25(6):e3487. PubMed ID: 36807469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis.
    Ding Z; Lan H; Xu R; Zhou X; Pan Y
    Pathol Res Pract; 2018 Dec; 214(12):1993-1999. PubMed ID: 30279010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
    Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
    Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA
    Xu W; Wang J; Xu J; Li S; Zhang R; Shen C; Xie M; Zheng B; Gu M
    J Int Med Res; 2022 Apr; 50(4):3000605221093135. PubMed ID: 35466755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.